Cross-sectional study investigates the impact of symptom and psychological burdens on treatment satisfaction in cancer patients, suggesting interventions for better support.
Background: Chemotherapy-related symptom burden and psychological distress may significantly influence patients’ perceptions of treatment convenience and satisfaction, yet evidence in the Greek oncology population remains limited. Methods: A cross-sectional study was conducted among 150 cancer patients receiving chemotherapy in a tertiary hospital. Data were collected using CCSQ, ESAS-r, PHQ-2, GAD-2, and WHO-5. Pearson correlations and multiple linear regression analyses were performed. Results: Higher levels of depressive symptoms and anxiety were significantly associated with lower chemotherapy convenience and satisfaction (e.g., PHQ-2: r = −0.659 to −0.584, p < 0.001; GAD-2: r = −0.623 to −0.469, p < 0.001). Depressed mood emerged as a significant negative predictor of convenience (β = −0.39, p = 0.015) and concerns (β = −0.39, p = 0.005), while anxiety independently predicted satisfaction (β = 0.45, p = 0.007). Conclusions: Chemotherapy experience is strongly associated with psychological and symptom burden. These findings highlight the importance of integrating psychosocial assessment into routine oncology care.
No takes yet. Share an insight, caveat, or question.
Fradelos et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: